価格表

在庫・価格 : 2025年07月01日 03時30分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Flt-3 Ligand, Human, Recombinant <Flk-2 Ligand>
データシート
308-FK-025 RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥100,000 2個 追加

在庫・価格 : 2025年07月01日 03時30分 現在

Flt-3 Ligand, Human, Recombinant <Flk-2 Ligand>

  • 商品コード:308-FK-025
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥100,000
  • 在庫:2個
使用文献
No. 文献情報 備考 参照
1 Drouet M et al. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation. Stem Cells 1999;17(5):273-85
Drouet M et al
1999/01/01
Species: Primate - Baboon, Application: Bioassay, Sample type: Whole Cells PubMed
2 Hoover RR et al. Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336. Blood 2002 Aug;100(3):1068-71
Hoover RR et al
2002/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Davis BM et al. In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication. Mol. Ther. 2004 Feb;9(2):160-72
Davis BM et al
2004/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
4 Lu SJ et al. CD34+CD38- hematopoietic precursors derived from human embryonic stem cells exhibit an embryonic gene expression pattern. Blood 2004 Jun;103(11):4134-41
Lu SJ et al
2004/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
5 McGuckin CP et al. Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells. Cell Prolif. 2004 Aug;37(4):295-306
McGuckin CP et al
2004/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
6 Allam JP et al. Transforming growth factor-beta1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro. J. Invest. Dermatol. 2004 Oct;123(4):676-82
Allam JP et al
2004/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Chiba H et al. Wnt3 modulates the characteristics and cobblestone area-supporting activity of human stromal cells. Exp. Hematol. 2004 Dec;32(12):1194-203
Chiba H et al
2004/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Barde I et al. Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Mol. Ther. 2006 Feb;13(2):382-90
Barde I et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
9 Yuan J et al. Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner. J. Immunol. 2006 Feb;176(4):2357-65
Yuan J et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
10 Kahl CA et al. Effects of busulfan dose escalation on engraftment of infant rhesus monkey hematopoietic stem cells after gene marking by a lentiviral vector. Exp. Hematol. 2006 Mar;34(3):369-81
Kahl CA et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
11 Sakamoto H et al. Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development. Blood 2006 Aug;108(3):896-903
Sakamoto H et al
2006/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
12 Hiroyama T et al. Long-lasting in vitro hematopoiesis derived from primate embryonic stem cells. Exp. Hematol. 2006 Jun;34(6):760-9
Hiroyama T et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
13 Kurita R et al. Tal1/Scl gene transduction using a lentiviral vector stimulates highly efficient hematopoietic cell differentiation from common marmoset (Callithrix jacchus) embryonic stem cells. Stem Cells 2006 Sep;24(9):2014-22
Kurita R et al
2006/01/01
Species: Primate - Callitrix jacchus (common marmoset), Application: Bioassay, Sample type: Whole Cells PubMed
14 Weerkamp F et al. Identification of Notch target genes in uncommitted T-cell progenitors: No direct induction of a T-cell specific gene program. Leukemia 2006 Nov;20(11):1967-77
Weerkamp F et al
2006/01/01
Application: Media Supplement, Sample Type: Whole Cells PubMed
15 Srivastava AS et al. Thrombopoietin enhances generation of CD34+ cells from human embryonic stem cells. Stem Cells 2007 Jun;25(6):1456-61
Srivastava AS et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
16 Sorrentino A et al. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp. Hematol. 2008 Aug;36(8):1035-46
Sorrentino A et al
2008/01/01
Species: Human, Application: Bioassay, Whole Cells PubMed
17 Liu R et al. Erythrocyte-derived microvesicles may transfer phosphatidylserine to the surface of nucleated cells and falsely &#39;mark&#39; them as apoptotic. Eur. J. Haematol. 2009 Sep;83(3):220-9
Liu R et al
2009/01/01
Application: Cell Preparation, Sample Type: Whole Cells PubMed
18 Ye L et al. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc. Natl. Acad. Sci. U.S.A. 2009 Jun;106(24):9826-30
Ye L et al
2009/01/01
Application: Cell Culture Substrate,differentiation, Sample Type: Whole Cells PubMed
19 Niwa A et al. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS ONE 2011;6(7):e22261
Niwa A et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
20 Gunetti M et al. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions. Exp. Hematol. 2008 Feb;36(2
Gunetti M et al
2008/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
21 Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
Wilson TR et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
22 Lee MR et al. Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. Stem Cells 2013 Apr;31(4):666-81
Lee MR et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
23 Doulatov S et al. Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 2013 Oct;13(4):459-70
Doulatov S et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
24 Takahashi M et al. CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells. Leukemia 2014 Jun;28(6):1308-15
Takahashi M et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
25 Csaszar E et al. Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine signaling. Blood 2014 Jan;123(5):650-8
Csaszar E et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
26 Uchida N et al. Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model. Gene Ther. 2014 Feb;21(2):148-57
Uchida N et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
27 Osaki Y et al. Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm? PLoS ONE 2013;8(11):e81722
Osaki Y et al
2013/01/01
Application: cell culture, Sample Type: cells PubMed
28 Kamat V et al. MicroRNA screen of human embryonic stem cell differentiation reveals miR-105 as an enhancer of megakaryopoiesis from adult CD34+ cells. Stem Cells 2014 May;32(5):1337-46
Kamat V et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
29 Reynolds C et al. Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia. Leukemia 2014 Sep;28(9):1819-27
Reynolds C et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
30 Chaurasia P et al. Epigenetic reprogramming induces the expansion of cord blood stem cells. J. Clin. Invest. 2014 Jun;124(6):2378-95
Chaurasia P et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
31 Yang CT et al. Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co-express gamma and beta globins. Br. J. Haematol. 2014 Aug;166(3):435-48
Yang CT et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
32 Khoo ML et al. Gene profiling reveals association between altered Wnt signaling and loss of T-cell potential with age in human hematopoietic stem cells. Aging Cell 2014 Aug;13(4):744-54
Khoo ML et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
33 Uchida N et al. Decitabine suspends human CD34+ cell differentiation and proliferation during lentiviral transduction. PLoS ONE 2014;9(8):e104022
Uchida N et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
34 Shen S et al. Small-molecule inhibitor of glycogen synthase kinase 3&#x3B2; 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice. Stem Cells Dev. 2015 Mar;24(6):724-36
Shen S et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
35 Barese CN et al. Regulated apoptosis of genetically modified hematopoietic stem and progenitor cells via an inducible caspase-9 suicide gene in rhesus macaques. Stem Cells 2015 Jan;33(1):91-100
Barese CN et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
36 Gerby B et al. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells. PLoS Genet. 2014 Dec;10(12):e1004768
Gerby B et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
37 Ratliff ML et al. Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells. J. Immunol. 2015 Feb;194(3):940-9
Ratliff ML et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
38 Matsuoka Y et al. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells. Stem Cells 2015 May;33(5):1554-65
Matsuoka Y et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
39 Berger A et al. Neurokinin-1 receptor signalling impacts bone marrow repopulation efficiency. PLoS ONE 2013;8(3):e58787
Berger A et al
2013/01/01
Application: cell culture, Sample Type: Whole Cells,cell PubMed
40 Tolar J et al. Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa. J. Invest. Dermatol. 2014 May;134(5):1246-54
Tolar J et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
41 Klimenkova O et al. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation. Blood 2014 Feb;123(8):1239-49
Klimenkova O et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
42 Wu C et al. Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells. Cell Stem Cell 2014 Apr;14(4):486-99
Wu C et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
43 Lee JB et al. Reversible lineage-specific priming of human embryonic stem cells can be exploited to optimize the yield of differentiated cells. Stem Cells 2015 Apr;33(4):1142-52
Lee JB et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
44 Jiang X et al. Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML). PLoS ONE 2015;10(4):e0122983
Jiang X et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
45 Hermanson DL et al. Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer. Stem Cells 2016 Jan;34(1):93-101
Hermanson DL et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
46 Nakagawa N et al. Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease. JCI Insight 2016 Dec;1(20):e87446
Nakagawa N et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
47 Baccelli I et al. A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens. Blood Cancer J 2017 Feb;7(2):e529
Baccelli I et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
48 Kotini AG et al. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia. Cell Stem Cell 2017 Mar;20(3):315-328.e7
Kotini AG et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Drouet M et al. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation. Stem Cells 1999;17(5):273-85
    Drouet M et al
    1999/01/01
  • 備考:
    Species: Primate - Baboon, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Hoover RR et al. Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336. Blood 2002 Aug;100(3):1068-71
    Hoover RR et al
    2002/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Davis BM et al. In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication. Mol. Ther. 2004 Feb;9(2):160-72
    Davis BM et al
    2004/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Lu SJ et al. CD34+CD38- hematopoietic precursors derived from human embryonic stem cells exhibit an embryonic gene expression pattern. Blood 2004 Jun;103(11):4134-41
    Lu SJ et al
    2004/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    McGuckin CP et al. Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells. Cell Prolif. 2004 Aug;37(4):295-306
    McGuckin CP et al
    2004/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Allam JP et al. Transforming growth factor-beta1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro. J. Invest. Dermatol. 2004 Oct;123(4):676-82
    Allam JP et al
    2004/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Chiba H et al. Wnt3 modulates the characteristics and cobblestone area-supporting activity of human stromal cells. Exp. Hematol. 2004 Dec;32(12):1194-203
    Chiba H et al
    2004/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Barde I et al. Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Mol. Ther. 2006 Feb;13(2):382-90
    Barde I et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Yuan J et al. Langerhans-type dendritic cells genetically modified to express full-length antigen optimally stimulate CTLs in a CD4-dependent manner. J. Immunol. 2006 Feb;176(4):2357-65
    Yuan J et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Kahl CA et al. Effects of busulfan dose escalation on engraftment of infant rhesus monkey hematopoietic stem cells after gene marking by a lentiviral vector. Exp. Hematol. 2006 Mar;34(3):369-81
    Kahl CA et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Sakamoto H et al. Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development. Blood 2006 Aug;108(3):896-903
    Sakamoto H et al
    2006/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Hiroyama T et al. Long-lasting in vitro hematopoiesis derived from primate embryonic stem cells. Exp. Hematol. 2006 Jun;34(6):760-9
    Hiroyama T et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Kurita R et al. Tal1/Scl gene transduction using a lentiviral vector stimulates highly efficient hematopoietic cell differentiation from common marmoset (Callithrix jacchus) embryonic stem cells. Stem Cells 2006 Sep;24(9):2014-22
    Kurita R et al
    2006/01/01
  • 備考:
    Species: Primate - Callitrix jacchus (common marmoset), Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Weerkamp F et al. Identification of Notch target genes in uncommitted T-cell progenitors: No direct induction of a T-cell specific gene program. Leukemia 2006 Nov;20(11):1967-77
    Weerkamp F et al
    2006/01/01
  • 備考:
    Application: Media Supplement, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Srivastava AS et al. Thrombopoietin enhances generation of CD34+ cells from human embryonic stem cells. Stem Cells 2007 Jun;25(6):1456-61
    Srivastava AS et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Sorrentino A et al. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp. Hematol. 2008 Aug;36(8):1035-46
    Sorrentino A et al
    2008/01/01
  • 備考:
    Species: Human, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Liu R et al. Erythrocyte-derived microvesicles may transfer phosphatidylserine to the surface of nucleated cells and falsely &#39;mark&#39; them as apoptotic. Eur. J. Haematol. 2009 Sep;83(3):220-9
    Liu R et al
    2009/01/01
  • 備考:
    Application: Cell Preparation, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Ye L et al. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc. Natl. Acad. Sci. U.S.A. 2009 Jun;106(24):9826-30
    Ye L et al
    2009/01/01
  • 備考:
    Application: Cell Culture Substrate,differentiation, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Niwa A et al. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS ONE 2011;6(7):e22261
    Niwa A et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Gunetti M et al. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical phase I/II protocol in European and Italian Good Manufacturing Practice conditions. Exp. Hematol. 2008 Feb;36(2
    Gunetti M et al
    2008/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
    Wilson TR et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Lee MR et al. Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming. Stem Cells 2013 Apr;31(4):666-81
    Lee MR et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Doulatov S et al. Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 2013 Oct;13(4):459-70
    Doulatov S et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Takahashi M et al. CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells. Leukemia 2014 Jun;28(6):1308-15
    Takahashi M et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Csaszar E et al. Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine signaling. Blood 2014 Jan;123(5):650-8
    Csaszar E et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Uchida N et al. Evaluation of engraftment and immunological tolerance after reduced intensity conditioning in a rhesus hematopoietic stem cell gene therapy model. Gene Ther. 2014 Feb;21(2):148-57
    Uchida N et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Osaki Y et al. Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm? PLoS ONE 2013;8(11):e81722
    Osaki Y et al
    2013/01/01
  • 備考:
    Application: cell culture, Sample Type: cells
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Kamat V et al. MicroRNA screen of human embryonic stem cell differentiation reveals miR-105 as an enhancer of megakaryopoiesis from adult CD34+ cells. Stem Cells 2014 May;32(5):1337-46
    Kamat V et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Reynolds C et al. Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia. Leukemia 2014 Sep;28(9):1819-27
    Reynolds C et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Chaurasia P et al. Epigenetic reprogramming induces the expansion of cord blood stem cells. J. Clin. Invest. 2014 Jun;124(6):2378-95
    Chaurasia P et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Yang CT et al. Human induced pluripotent stem cell derived erythroblasts can undergo definitive erythropoiesis and co-express gamma and beta globins. Br. J. Haematol. 2014 Aug;166(3):435-48
    Yang CT et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Khoo ML et al. Gene profiling reveals association between altered Wnt signaling and loss of T-cell potential with age in human hematopoietic stem cells. Aging Cell 2014 Aug;13(4):744-54
    Khoo ML et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Uchida N et al. Decitabine suspends human CD34+ cell differentiation and proliferation during lentiviral transduction. PLoS ONE 2014;9(8):e104022
    Uchida N et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Shen S et al. Small-molecule inhibitor of glycogen synthase kinase 3&#x3B2; 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice. Stem Cells Dev. 2015 Mar;24(6):724-36
    Shen S et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Barese CN et al. Regulated apoptosis of genetically modified hematopoietic stem and progenitor cells via an inducible caspase-9 suicide gene in rhesus macaques. Stem Cells 2015 Jan;33(1):91-100
    Barese CN et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Gerby B et al. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells. PLoS Genet. 2014 Dec;10(12):e1004768
    Gerby B et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Ratliff ML et al. Differential expression of the transcription factor ARID3a in lupus patient hematopoietic progenitor cells. J. Immunol. 2015 Feb;194(3):940-9
    Ratliff ML et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Matsuoka Y et al. Prospectively Isolated Human Bone Marrow Cell-Derived MSCs Support Primitive Human CD34-Negative Hematopoietic Stem Cells. Stem Cells 2015 May;33(5):1554-65
    Matsuoka Y et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Berger A et al. Neurokinin-1 receptor signalling impacts bone marrow repopulation efficiency. PLoS ONE 2013;8(3):e58787
    Berger A et al
    2013/01/01
  • 備考:
    Application: cell culture, Sample Type: Whole Cells,cell
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Tolar J et al. Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa. J. Invest. Dermatol. 2014 May;134(5):1246-54
    Tolar J et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Klimenkova O et al. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation. Blood 2014 Feb;123(8):1239-49
    Klimenkova O et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Wu C et al. Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells. Cell Stem Cell 2014 Apr;14(4):486-99
    Wu C et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Lee JB et al. Reversible lineage-specific priming of human embryonic stem cells can be exploited to optimize the yield of differentiated cells. Stem Cells 2015 Apr;33(4):1142-52
    Lee JB et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Jiang X et al. Functional Characterization of D9, a Novel Deazaneplanocin A (DZNep) Analog, in Targeting Acute Myeloid Leukemia (AML). PLoS ONE 2015;10(4):e0122983
    Jiang X et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Hermanson DL et al. Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer. Stem Cells 2016 Jan;34(1):93-101
    Hermanson DL et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Nakagawa N et al. Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease. JCI Insight 2016 Dec;1(20):e87446
    Nakagawa N et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Baccelli I et al. A novel approach for the identification of efficient combination therapies in primary human acute myeloid leukemia specimens. Blood Cancer J 2017 Feb;7(2):e529
    Baccelli I et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Kotini AG et al. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia. Cell Stem Cell 2017 Mar;20(3):315-328.e7
    Kotini AG et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed